Covidien plc  

(Public, NYSE:COV)   Watch this stock  
Find more results for cov
106.71
0.00 (0.00%)
After Hours: 107.05 +0.34 (0.32%)
Jan 26, 6:35PM EST  
NYSE real-time data - Disclaimer
Currency in USD
Range     -
52 week 65.97 - 108.57
Open     -
Vol / Avg. 0.00/3.88M
Mkt cap 48.98B
P/E 27.41
Div/yield 0.36/1.35
EPS 3.89
Shares 454.51M
Beta 1.01
Inst. own 96%
Apr 23, 2015
Q2 2015 Covidien Public Limited Company Earnings Release (Estimated)
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 19.02% 15.59%
Operating margin 23.72% 18.69%
EBITD margin - 25.42%
Return on average assets 9.92% 8.18%
Return on average equity 20.06% 17.22%
Employees 39,500 -
CDP Score - 78 C

Address

20 On Hatch Lower Hatch Street, Dublin 2
DUBLIN,
Ireland
+353-1-4381700 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Covidien Public Limited Company is a healthcare products company. The Company is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. The Company’s brands include Kendall, Nellcor, Puritan Bennett and Valleylab, among others. It has a presence in more than 70 countries, with products sold in over 150 countries. The Company’s segments include Medical Devices and United States Medical Supplies. Medical Devices includes marketing of advanced and general surgical solutions, peripheral vascular and neurovascular therapies, patient monitoring products, and airway and ventilation products. United States Medical Supplies includes products, such as nursing care, medical surgical, SharpSafety and original equipment manufacturer (OEM) products. The Company’s products include Surgical Solutions, Vascular Therapies, Respiratory and Patient Care.